Two cohort studies used PD1 to treat melanoma, two cohort studies used CTLA4 to treat melanoma, one cohort study combined PD1 with CTLA4 to treat melanoma, and one cohort study used PD1 to treat gastric cancer. This evidence concerns the gene CTLA4 and melanoma.